The Impact of age and outcomes of high-risk patients on carotid revascularization.
Joon-Kee ParkShin-Young WooYang-Jin ParkDong-Ik KimGyeong-Moon KimWoo-Keun SeoJong-Won JungPyoung JeonKeon-Ha KimYoung-Wook KimShin-Seok YangPublished in: Vascular (2023)
In patients older than 75 years in the Hr group, there were relatively poor 30-day treatment outcomes in both CEA and CAS. Alternative treatment is needed that can expect better outcomes in older high-risk patients. In the Nr group, CEA has a significant benefit compared with CAS, and CEA should be recommended more to these patients.